Dx dialogues: using molecular profiling to identify mutations in R/R AML

Naval Daver, MD, explains how high-resolution genomic profiling can help us identify actionable mutations in R/R AML.

Identifying gene mutations is an important step in diagnosing AML and determining the best approach to treatment.

An overview of the therapies used when acute myeloid leukemia (AML) doesn’t respond to treatment or comes back after treatment.

Mutations to the FLT3 gene are common in AML. Here’s what these mutations mean for prognosis and treatment.

What to ask your cancer care team when starting any new treatment for a desmoid tumor, including medications and surgery.

An overview of therapies used to treat desmoid tumors, including active surveillance, targeted therapies, and surgery.